EVOEvotec SE American Depositary Shares

NAS · US · Healthcare · Drug Manufacturers - Specialty & Generic · evotec.com

1.930USDMkt Cap: 685.90M $P/E: —3d ago

Evotec SE operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally. It operates in two segments, Shared R&D and Just Evotec Biolog…

Industry Peers

Drug Manufacturers - Specialty & Generic

Screen all

MRK

MERCK Kommanditgesellschaft auf Aktien

$65.19BUSDP/E 23.7

TAK

Takeda Pharmaceutical Co. Ltd.

$58.06BUSD

HLN

Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

$43.98BUSDP/E 20.4

TEVA

Teva Pharmaceutical Industries Limited

United Therapeutics Corporation

Swedish Orphan Biovitrum AB

Neurocrine Biosciences, Inc.

$15.51BUSDP/E 22.3

ELAN

Elanco Animal Health Incorporat

$11.98BUSD

RDY

Dr. Reddy's Laboratories Ltd

Hims & Hers Health, Inc.

$7.88BUSD

LNTH

Lantheus Holdings Inc

$6.53BUSDP/E 23.9

AMRX

Amneal Pharmaceuticals, Inc. Class A

Kiniksa Pharmaceuticals, Ltd.

$6.08BUSDP/E 79.8

Key Statistics

Company

Market Cap685.90M $

Enterprise Value696.10M $

Revenue (TTM)717.28M $

Gross Profit114.22M $

Net Income (TTM)-103.52M $

Revenue/Share2.019 USD

Last Price1.930 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees4.5K

CountryUS

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-10.16

PEG1.42

EV/EBITDA-9.51

EV/Revenue0.97

P/S0.96

P/B0.88

EPS (TTM)-0.65

EPS (Forward)-0.19

52W Range

1.91543% of range1.950

52W High1.950 USD

52W Low1.915 USD

Profitability

Gross Margin14.49%

Oper. Margin-62.26%

EBITDA Margin-10.20%

Profit Margin-13.13%

ROE-12.72%

ROA-6.04%

Growth

Revenue Growth-16.20%

Earnings Growth—

Cash Flow & Leverage

Operating CF-9.18M $

CapEx (TTM)82.62M $

FCF Margin-11.29%

FCF Yield-11.81%

Net Debt10.28M $

Net Debt/EBITDA-0.14

Balance Sheet

Debt/Equity0.55

Current Ratio2.33

Quick Ratio2.02

Book Value/Sh2.186 USD

Cash/Share1.310 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split4:1

Split DateOct 20, 2021

Analyst Consensus

Rating2.5 (Hold)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)3.865 USD

Upside (mean)+100.2%

Target Range2.027 USD – 6.948 USD

$2.027+100.2% to mean$6.948

# Analysts4

Ownership

Shares Out.355.39M

Float270.77M

Insiders0.01%

Institutions0.81%

Short Interest

Short Ratio0.8d

Short % Float0.01%

Short % Out.0.01%

Shares Short47.63K

Short (prev mo.)53.01K

Technical

SMA 502.299 (-16.0%)

SMA 2002.899 (-33.4%)

Beta1.26

S&P 52W Chg19.18%

Avg Vol (30d)40.68K

Avg Vol (10d)42.73K

Technical Indicators

RSI (14)39.2

MACD-0.0837

MACD Signal-0.1017

MACD Hist.+0.0180

BB Upper2.120 USD

BB Middle1.978 USD

BB Lower1.836 USD

BB Width14.40%

ATR (14)0.0823 USD

Vol Ratio (20d)0.58x